A Family Literacy Program for Latino Families

Sponsor
Rutgers, The State University of New Jersey (Other)
Overall Status
Completed
CT.gov ID
NCT03941197
Collaborator
(none)
14
1
1
4
3.5

Study Details

Study Description

Brief Summary

A pilot study of a health-focused family literacy program. The program will consist of a series of 8 weekly workshops centered around different health topics (e.g. physical activity) that introduce basic literacy skills. The workshops are designed for children entering kindergarten and their parents

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Ready and Healthy for Kindergarten Family Literacy program
N/A

Detailed Description

This is a pilot study of a health-focused family literacy program. The program consists of 8 weekly health-themed workshops designed to introduce basic literacy skills to children entering Kindergarten and their parents. There will be a pre and post test assessment for participating parents and children. During the 8 weeks, parents will receive 2-3 weekly text messages to reinforce material presented at the weekly workshop.

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Ready and Healthy for Kindergarten- A Family Literacy Program for Latino Families
Actual Study Start Date :
May 28, 2019
Actual Primary Completion Date :
Sep 28, 2019
Actual Study Completion Date :
Sep 28, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ready and Healthy for Kindergarten Family Literacy Program

Ready and Healthy for Kindergarten Family Literacy Program- 8 weekly parent child workshops with text message reminders

Behavioral: Ready and Healthy for Kindergarten Family Literacy program
Participants will participate in 8 parent-child health-themed literacy workshops. Participants will receive 2-3 text messages per week for 8 weeks.

Outcome Measures

Primary Outcome Measures

  1. Acceptability of Intervention Measure (AIM) Questionnaire [After 8 week period.]

    Acceptability will be measured using the Acceptability of Intervention Measure (AIM). The AIM consists of 4 questions that assess acceptability. Responses range from 1 (completely disagree) to 5 (completely agree). Scales are created by averaging responses.

Secondary Outcome Measures

  1. StimQ-Preschool survey [At enrollment and after 8 week period.]

    Parent reported measure of the cognitive home environment for children 5 months to 6 years to assess aspects of the home environment that affect child development.

  2. Alphabet knowledge assessment survey [At enrollment and after 8 week period.]

    Alphabet knowledge will be assessed.

  3. Sight word knowledge assessment survey [At enrollment and after 8 week period.]

    Sight word knowledge will be assessed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Preferred language is either Spanish or English.

  • Parent or legal guardian of child

  • Parent age 18 or older

  • Willing to accept text messages

Exclusion Criteria:
  • Children not entering Kindergarten in Fall 2019 and their parents will be excluded

Contacts and Locations

Locations

Site City State Country Postal Code
1 Manuel E Jimenez New Brunswick New Jersey United States 08901

Sponsors and Collaborators

  • Rutgers, The State University of New Jersey

Investigators

  • Principal Investigator: Manuel E Jimenez, MD, MS, Rutgers Robert Wood Johnson Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Manuel E. Jimenez, MD, MS, Assistant Professor, Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT03941197
Other Study ID Numbers:
  • Pro2019000570
First Posted:
May 7, 2019
Last Update Posted:
Feb 18, 2020
Last Verified:
Feb 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Manuel E. Jimenez, MD, MS, Assistant Professor, Rutgers, The State University of New Jersey

Study Results

No Results Posted as of Feb 18, 2020